Since EGFR is well-established as being up-regulated/over expressed in breast cancers with amplification and mutations especially prevalent in >60% of TNBC cases [46], it is one possibility for the increased toxicity observed in TNBC cells versus the normal cells. The gene discussed is EGFR; the disease is breast cancer.